Document is current
Any future updates will be listed below
-
Authors
Atallah-Yunes, Suheil Albert https://orcid.org/0000-0003-3380-5326
Habermann, Thomas M. https://orcid.org/0000-0003-3532-9132
Rees, Matthew J. https://orcid.org/0000-0001-8360-2952
Ng, Lay She
Durani, Urshila https://orcid.org/0000-0003-1860-2424
Wang, Yucai https://orcid.org/0000-0002-1576-8341
King, Rebecca L.
Khurana, Arushi https://orcid.org/0000-0001-5645-0949
- License Information
-
More Information
Article History
Received: 17 July 2025
Revised: 28 August 2025
Accepted: 17 September 2025
First Online: 16 October 2025
Competing interests
: TMH:Data Monitoring Committee-Eli Lilly. All other authors declare no competing interests.
: The study was approved by the May Clinic Institutional Review Board. The study was conducted in compliance with the Declaration of Helsinki. Given the retrospective nature of the study, a waiver of consent was obtained.
